Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'


According to a market report by Lucintel, the future of the subcutaneous drug delivery device market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels. The global subcutaneous drug delivery device market is expected to reach an estimated $44.0 billion by 2028 with a CAGR of 9% from 2023 to 2028. The major drivers for this market are increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunisation campaign.



In this market, prefilled syringe, pen injector, auto-injector, wearable injector, and needle-free injector are the major segments of subcutaneous drug delivery device market by product. Lucintel forecasts that pen injector will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost effectiveness, and high societal acceptance.



Within this market, retail pharmacy is expected to remain the largest segment due to patients’ growing preference for physical pharmacies owing to quick availability of medication and expanding number of retail pharmacies.



North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.

Gerresheimer, Medtronic, Ypsomed, Elcam Medical Group, and Novo Nordisk are the major suppliers in the global subcutaneous drug delivery device market.  



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global subcutaneous drug delivery device market by product, distribution channel, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Subcutaneous Drug Delivery Device Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global subcutaneous drug delivery device market by product, distribution channel, and region, as follows:


Subcutaneous Drug Delivery Device Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Prefilled Syringes


  • Pen Injectors


  • Auto-Injectors


  • Wearable Injectors


  • Needle-Free Injectors



Subcutaneous Drug Delivery Device Market by Distribution Channel [Value ($B) Shipment Analysis from 2017 to 2028]:




  • Hospital Pharmacies


  • Retail Pharmacies


  • Online Pharmacies



Subcutaneous Drug Delivery Device Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:




  • North America


  • Europe


  • Asia Pacific


  • The Rest of the World



This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 


About Lucintel



Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 


This report answers the following 11 key questions:



Q.1. What are some of the most promising, high-growth opportunities for the subcutaneous drug delivery device market by product (prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?